Tubulocystic Renal Cell Carcinoma: A Scoping Review of 30 Cases

30 published cases of the rare tubulocystic renal cell carcinoma were analyzed in a scoping review. The dataset, authored by figshare admin karger and last updated in 2026, includes findings on tumor laterality, size, associated malignancies, and immunohistochemical markers. Results show a left-sided predominance in 63.3% of cases and frequent positivity for AMACR (66.7%) and CD10 (46.7%).

Use Cases

• Analyzing tumor laterality and site distribution based on reported case data
• Investigating associations with concurrent malignancies, particularly papillary renal cell carcinoma
• Evaluating the diagnostic utility of immunohistochemical markers like AMACR and CD10
• Studying the clinical behavior of TC-RCC, including rates of extra-renal extension and metastasis

Strengths

• Includes data from 30 published TC-RCC cases, providing a focused sample for a rare condition
• Reports specific percentages for key findings, such as 63.3% left-sided predominance and 66.7% AMACR positivity
• Data collection covers multiple clinicopathological dimensions: tumor size, stage, extension, and immunohistochemistry

Limitations

• Row count is unknown, which may limit suitability assessment
• Column-level documentation is absent; field semantics must be inferred after download
• The dataset is very small at 86.9 KB, indicating limited scope

Provenance

Source

figshare

Collection Method

Scoping review of published literature

Freshness

Last updated 2026-05-21 09:55:23; freshness should be verified